Hyperfine Inc(HYPR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 7:39 PM ET (Korea 10/31 08:39)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.38 | Insider Own | 19.88% | Shs Outstand | 91.0M | Perf Week | -0.94% |
| Market Cap | 0.08B | Forward P/E | - | EPS next Y | 7.54% | Insider Trans | -0.13% | Shs Float | 85.0M | Perf Month | -17.68% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | -0.08 | Inst Own | 18.23% | Short Float | 4.44% | Perf Quarter | -26.87% |
| Income | -0.03B | P/S | 4.6 | EPS this Y | 20.35% | Inst Trans | 16.02% | Short Ratio | 5.15 | Perf Half Y | -61.63% |
| Sales | 0.02B | P/B | 2.07 | EPS next 5Y | 12.3% | ROA | -64.4% | Short Interest | 3.77M | Perf YTD | -26.72% |
| Book/sh | 0.35 | P/C | 1.7 | EPS past 3/5Y | 25.18% 14.09% | ROE | -96.97% | 52W High | -62.91% ($1.93) | Perf Year | -35.35% |
| Cash/sh | 0.42 | P/FCF | - | Sales past 3/5Y | 25.79% 115.18% | ROIC | -69.71% | 52W Low | 3.18% ($0.70) | Perf 3Y | -43.05% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 27.17% | Gross Margin | 51.41% | Volatility(W/M) | 6.36% 7.62% | Perf 5Y | -92.81% |
| Dividend TTM | - | EV/Sales | 2.71 | Sales Y/Y TTM | 53.16% | Oper. Margin | -203.27% | ATR (14) | 0.05 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 5.45 | EPS Q/Q | 21.15% | Profit Margin | -210.75% | RSI (14) | 38.18 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.15 | Sales Q/Q | 44.81% | SMA20 | -10.48% ($0.8) | Beta | 1.49 | Target Price | $2.02 |
| Payout | - | Debt/Eq | 0.36 | Earnings | 2026/11/9 | SMA50 | -11.68% ($0.82) | Rel Volume | 0.77 | Prev Close | $0.74 |
| Employees | 102 | LT Debt/Eq | 0.36 | EPS/Sales Surpr. | - -5.58% | SMA200 | -36.53% ($1.13) | Avg Volume(3M) | 0.73M | Price | $0.72 |
| IPO | 2021/1/27 | Option/Short | Yes/Yes | Trades | 2166 | Volume | 565,605 | Change | -3.5% |
🧲 Hyperfine is a US medical device company that developed Swoop, the world's first portable low-field MRI system. Unlike traditional large-scale MRI machines, the Swoop can be brought directly to a patient's bedside to capture brain images, focusing on lowering the barrier to neuroimaging diagnostics in access-limited settings such as emergency rooms and intensive care units.
Over the past 1 year, on the lower side
63% below its 1-year high.
Traded less than usual. That is 77% of its average volume.
Next earnings report: November 9
7 days to go.
HYPR has a sound balance sheet but weak earning power
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +20.4% this year.
Tap to view numbers
Relative to sales, it looks expensive
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $460. Peers typically go for $143.
Tap to view numbers
Results came in about as expected
Slight tendency to miss estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -92.8%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 18.2%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #89 of 142 in the industry
Based on market cap of $76M.
SERA#88 Sera Prognostics Inc $80M PER - HYPR#89 Hyperfine Inc $76M PER - 
OM#90 Outset Medical Inc $76M PER - 
MBOT#91 Microbot Medical Inc $73M PER - 
LNSR#92 LENSAR Inc $72M PER - 
FAQ
What kind of company is HYPR?
HYPR belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of HYPR?
The market cap of HYPR is approximately $76M, ranking 4,623 within its sector.
What is the 52-week high and low for HYPR?
HYPR has recorded a 52-week high of $1.93 and a low of $0.70.
